Efficiency of antidiabetic Combinatorial Treatment in non-alcoholic Fatty Liver Disease and Type-2-Diabetes

被引：0
|
作者：
Kahl, S. [1 ]
机构：
[1] Heinrich Heine Univ, Inst Klin Diabetol, Leibniz Zentrum Diabet Forsch, Deutsch Diabet Zentrum, Aufm Hennekamp 65, D-40225 Dusseldorf, Germany
来源：
DIABETOLOGE | 2018年 / 14卷 / 08期
关键词：
D O I：
10.1007/s11428-018-0422-z
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：601 / 602
页数：2
相关论文
共 50 条
  • [21] Non-alcoholic fatty liver disease and diabetes
    Hazlehurst, Jonathan M.
    Woods, Conor
    Marjot, Thomas
    Cobbold, Jeremy F.
    Tomlinson, Jeremy W.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2016, 65 (08): : 1096 - 1108
  • [22] Ipragliflozin for the Treatment of Fatty Liver Disease in Type-2-Diabetes
    Kahl, S.
    DIABETOLOGE, 2022, 18 (01): : 67 - 68
  • [23] The roles of type 2 diabetes and obesity in disease activity and progression of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis
    Shinde, Shraddha
    Nelson, David R.
    Mitroi, Jessica
    Heaton, Pamela C.
    Hincapie, Ana L.
    Brouwers, Bram
    CURRENT MEDICAL RESEARCH AND OPINION, 2024, 40 (01) : 59 - 68
  • [24] Empagliflozin as metabolically active compound for treatment of non-alcoholic fatty liver disease in type 2 diabetes
    Kahl, S.
    Gancheva, S.
    Strassburger, K.
    Herder, C.
    Machann, J.
    Kupriyanova, Y.
    Kabisch, S.
    Henkel, E.
    Kantartzis, K.
    Kopf, S.
    Kasperk, C.
    Stefan, N.
    Pfeiffer, A.
    Birkenfeld, A. L.
    Roden, M.
    DIABETOLOGIA, 2019, 62 : S124 - S124
  • [25] Non-alcoholic fatty liver disease and type 2 diabetes mellitus: The liver disease of our age?
    Firneisz, Gabor
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (27) : 9072 - 9089
  • [26] Non-alcoholic fatty liver disease and type 2 diabetes mellitus: The liver disease of our age?
    Gábor Firneisz
    World Journal of Gastroenterology, 2014, (27) : 9072 - 9089
  • [27] Intestine-liver crosstalk in Type 2 Diabetes and non-alcoholic fatty liver disease
    Nawrot, Margaux
    Peschard, Simon
    Lestavel, Sophie
    Staels, Bart
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 123
  • [28] Non-alcoholic fatty liver disease is associated with an increased risk of type 2 diabetes
    Loosen, Sven H.
    Krieg, Sarah
    Krieg, Andreas
    Qvartskhava, Natalia
    Luedde, Tom
    Kostev, Karel
    Roderburg, Christoph
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2023, 35 (06) : 662 - 667
  • [29] Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetes
    Seo, D. H.
    Lee, Y-H
    Park, S. W.
    Choi, Y. J.
    Huh, B. W.
    Lee, E.
    Huh, K. B.
    Kim, S. H.
    Cha, B-S
    DIABETES & METABOLISM, 2020, 46 (05) : 362 - 369
  • [30] Cardiorespiratory fitness in patients with type 2 diabetes and non-alcoholic fatty liver disease
    Afolabi, P. R.
    Scorletti, E.
    Calder, P. C.
    Byrne, C. D.
    DIABETIC MEDICINE, 2020, 37 : 45 - 45
12345